In T2D, although GIP levels may be normal or even elevated, β-cells become refractory to GIP’s insulinotropic effect, whereas GLP-1 retains partial activity—a selective “incretin resistance” for GIP that remains incompletely understood [8]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.